null
EyePromise® Launches the Next Generation of MPOD Measurement Device

EyePromise® Launches the Next Generation of MPOD Measurement Device

Posted by EyePromise on Jun 8th 2023

#1 Eye Doctor Recommended Eye Vitamins Reveals the Future of Macular Pigment Optical Density (MPOD) Measurement – and It’s Portable

CHESTERFIELD – MO – May XX, 2023 — EyePromise, the industry-leading eye health nutraceutical company, has announced the latest addition to its comprehensive nutritional system for eye care practices. The new Zx Pro™ is the latest in biomarker technology and allows eye care professionals to measure macular pigment optical density in a larger patient base. This portable, intuitive device is equipped with an audio tutorial, making the need for staff-run exams discretionary and ensuring each test is completed accurately.

How Does It Work?

Using clinically proven technology called heterochromatic flicker photometry, the Zx Pro’s 2-minute ocular test provides a score that directly correlates to the amount of dietary zeaxanthin and lutein in the eyes. This gives doctors a quantified measure to associate with patients’ level of risk. Low macular pigment optical density (MPOD) scores are a risk factor for several eye and overall health concerns, including blue light damage, poor contrast, difficulty seeing at night, light sensitivity, cognitive concerns, and of course, age-related eye health issues.

Pinakin Davey, PhD, OD, FAAO, a tenured professor at Western University of Health Sciences, College of Optometry and one of the clinical experts behind the research that developed the Zx Pro, explained,

The idea for the Zx Pro grew from an understanding that MPOD is an invaluable biomarker combined with a need for a device that’s portable, creating flexibility for both research and practice purposes. We also wanted to include features such as the audio tutorial to reduce staff requirements and variability of the exam explanation from patient to patient. It’s the latest cutting-edge technology to improve early patient identification and intervention. A remarkable achievement for both clinical and practical use.

Andreas Wolf, EyePromise President, echoed Dr. Davey’s excitement.

This is a game-changing device for our eye care partners and their patients. Because MPOD measurement can be utilized as a biomarker for eye and overall health and the exam is so fast and easy, it opens the opportunity for a broader audience to be measured and benefit from ocular nutrition. This allows more patients to be helped sooner, creating an invaluable measurement for vision for life.

The New Zea Performance System™

The Zx Pro joins EyePromise’s comprehensive line of clinically proven nutraceuticals and the Auto Refill Program (ARP), the industry-leading patient compliance program. These are all part of the new Zea Performance System, the nutritional program that helps deliver vision for life through a turnkey solution for MPOD measurement, nutraceutical prescription, a compliance program, and patient and practice support.

For more information, visit eyepromise.com/zea-performance-system.

###

EyePromise® provides unmatched expertise in nutrition science and is the leading provider of nutritional supplements and technologies that support eye health. The EyePromise eye supplement line covers a full range of eye health needs, including macular health, occasional dry eye, screen time, and athletic visual performance. We are the #1 eye doctor-recommended vitamins with thousands of U.S. optometrists prescribing and hundreds of millions of dosages consumed nation wide. Our NSF Certified for Sport® performance supplements are scientifically formulated to give athletes an edge and support players in professional football, baseball, hockey, basketball. EyePromise is the official eye vitamin of the Boston Red Sox, Golfzon Leadbetter, and the PGA Golf Retirement Plus program. For more information on improving eye care with EyePromise, visit: EyePromise.com.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.